Fluvoxamine Maleate

Product NDC
0832-6025
Requested package NDC
0832-6025-30
11-digit product format
008326025
Labeler code
0832
Product ID
0832-6025_e8d5c618-7a45-447a-bb44-71c9fe5b10c5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Fluvoxamine Maleate
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Labeler
Upsher-Smith Laboratories, LLC
Application
ANDA220328
Marketing category
ANDA
Marketing start
2026-04-30
Substance
FLUVOXAMINE MALEATE
Active strength
100 mg/1
Pharmacologic classes
Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A220328-001FLUVOXAMINE MALEATEFLUVOXAMINE MALEATE100MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-30
A220328-002FLUVOXAMINE MALEATEFLUVOXAMINE MALEATE150MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A220328-001AB
A220328-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A220328-001FLUVOXAMINE MALEATE100MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-30d4dbc9d85df4…
2026-11-14 07:37:172026-10A220328-002FLUVOXAMINE MALEATE150MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-30d4dbc9d85df4…
2026-10-15 13:18:302026-09A220328-001FLUVOXAMINE MALEATE100MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-30c2088c7a36db…
2026-10-15 13:18:302026-09A220328-002FLUVOXAMINE MALEATE150MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-30c2088c7a36db…
2026-09-14 22:38:342026-08A220328-001FLUVOXAMINE MALEATE100MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-3084e616aacf4f…
2026-09-14 22:38:342026-08A220328-002FLUVOXAMINE MALEATE150MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-3084e616aacf4f…
2026-08-18 06:07:402026-07A220328-001FLUVOXAMINE MALEATE100MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-30caaa826d4ba7…
2026-08-18 06:07:402026-07A220328-002FLUVOXAMINE MALEATE150MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-30caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220328-001FLUVOXAMINE MALEATE100MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-30a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220328-002FLUVOXAMINE MALEATE150MGCAPSULE, EXTENDED RELEASE / ORALAB2026-04-30a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A220328-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A220328-002AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A220328-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A220328-002AB1c2088c7a36db…
2026-09-14 22:38:342026-08A220328-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A220328-002AB184e616aacf4f…
2026-08-18 06:07:402026-07A220328-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A220328-002AB1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220328-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220328-002AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Fluvoxamine Maleate
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
FLUVOXAMINE MALEATE100 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5LGN83G74VInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
903873Internal RxNorm lookup
903879Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
49601858-df61-4522-ac99-0d2892f92e11Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Fluvoxamine MaleateFLUVOXAMINE MALEATEUpsher-Smith Laboratories, LLC49601858-df61-4522-ac99-0d2892f92e112026-05-14Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 220328
application number: ANDA220328
ndc (package): 0832-6025-30
ndc (product): 0832-6025
ndc11 (package): 00832602530

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
0832-6025-300083260253030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-6025-30) 2026-05-15NoNoCurrent